CITURGIBIO

Citurgia Biochemicals Share Price

 

 

Start SIP in CITURGIBIO

Start SIP

Performance

  • Low
  • ₹52
  • High
  • ₹52
  • 52 Week Low
  • ₹47
  • 52 Week High
  • ₹52
  • Open Price₹52
  • Previous Close₹50
  • Volume480
  • 50 DMA-
  • 100 DMA-
  • 200 DMA-

Investment Returns

  • Over 1 Month -66.97%
  • Over 3 Month -66.97%
  • Over 6 Month -66.97%
  • Over 1 Year -66.97%

Smart Investing Starts Here Start SIP with Citurgia Biochemicals for Steady Growth!

Invest Now

Citurgia Biochemicals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -1645.2
  • PEG Ratio
  • -155.9
  • Market Cap Cr
  • 690
  • P/B Ratio
  • -72.7
  • Average True Range
  • -
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • -
  • MFI
  • -

Citurgia Biochemicals Financials

Citurgia Biochemicals Technicals

EMA & SMA

Current Price
₹52.25
+ 2.48 (4.98%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • -
  • 50 Day
  • -
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

52.25 Pivot Speed
  • R3 52.25
  • R2 52.25
  • R1 52.25
  • S1 52.25
  • S2 52.25
  • S3 52.25

Citurgia Biochemicals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-14 Quarterly Results
2025-11-14 Quarterly Results
2025-08-29 A.G.M.
2025-08-14 Quarterly Results
2025-05-30 Audited Results

Citurgia Biochemicals F&O

Citurgia Biochemicals Shareholding Pattern

No data available.

Citurgia Biochemicals FAQs

Citurgia Biochemicals share price is ₹52 As on 12 February, 2026 | 06:04

The Market Cap of Citurgia Biochemicals is ₹690.2 Cr As on 12 February, 2026 | 06:04

The P/E ratio of Citurgia Biochemicals is -1645.2 As on 12 February, 2026 | 06:04

The PB ratio of Citurgia Biochemicals is -72.7 As on 12 February, 2026 | 06:04

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23